In-vitro assessment of first-line antifungal drugs against Aspergillus spp. caused human keratomycoses
Natamycin
Clotrimazole
Econazole
Fungal Keratitis
Aspergillus terreus
Aspergillus niger
DOI:
10.1016/j.jiph.2020.10.014
Publication Date:
2020-11-06T03:50:34Z
AUTHORS (13)
ABSTRACT
Aspergillus keratitis are in the increasing trend and reported as second most common cause of mycotic developing countries. The present study was designed to isolate, identify spp. from keratits/corneal ulcer patients attending a tertiary care eye hospital, Coimbatore, South India assess minimum inhibitory concentrations (MICs) against ten clinically used first-line antifungal drugs. A total seventy-three strains isolated corneal scrapings were included assessed for period one year. All isolates identified up species level by morphological observations. Antifungal drug susceptibilities determined standard panel agents. Five different aspergilli, A. flavus (n=53), fumigatus (n=14), terreus (n=9), tamarii (n=6) niger (n=3) based on features. Minimum concentration analyses indicated that, voriconazole, natamycin, itraconazole, clotrimazole, econazole followed ketoconazole shall be order choices effective treatment keratitis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (44)
CITATIONS (6)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....